Avac Event
The Conference on Retroviruses and Opportunistic Infections (CROI) is a scientifically focused meeting of the world’s leading researchers working to understand, prevent, and treat HIV/AIDS and its complications.
The goal of CROI is to provide a forum for translating laboratory and clinical research into progress against the AIDS epidemic. Over 4,000 leading researchers and clinicians from around the world convene in a different location each year for the Conference.
Avac Event
USCA is the largest AIDS-related gathering in the US, bringing together thousands of workers from all fronts of the HIV/AIDS epidemic to build national support networks and exchange the latest information. In 2014, USCA “will continue to highlight how the Affordable Care Act can help us draw even closer to ending the epidemic, while focusing on the challenges we still have to overcome to achieve this vision.”
Avac Event
The International AIDS Conference, or AIDS 2014, is a biennial gathering for those working in the field of HIV, as well as policy makers, persons living with HIV and other individuals committed to ending the pandemic.
Much of the conference is available online. All sessions presented at the conference, aside from workshops, were recorded and uploaded to the conference YouTube page and the Programme-at-a-Glance.
In addition:
AVAC prepared a full roadmap highlighting sessions throughout the conference—available as a PDF and an Excel spreadsheet, sortable by prevention option and more.
Avac Event
Cape Town International Convention Centre in Cape Town, South Africa
The HIV Research for Prevention (R4P) conference is the first global conference to cover all forms of biomedical HIV prevention, including AIDS vaccines, microbicides, PrEP, treatment as prevention and other approaches.
The conference concluded on Friday, October 31 but session webcasts and conference reports are available below as are links to slides and the recording of AVAC’s post-R4P webinar—The State of the HIV Prevention Union: The Road from R4P.
Each day, AVAC offered up a selective, whirlwind tour through the day’s sessions—check them out below:
The conference has made all of the oral presentations, including the opening and closing sessions, available as webcasts. Download them here.
WhatsUpHIV is a live blog set up to report developments from HIV R4P. Over 50 entries were published from advocates, community journalists and researchers.
Visit the social media archive of the conference on Twitter and Facebook via #HIVR4P.
Ken Mayer has a great summary of the conference in the Lancet.
Download a comprehensive 107-page document of media clippings.
The CBC has dispatches from the conference including news about RV144 and next steps, the growing responsibility of African countries in fighting HIV/AIDS and the advantages of a microbicide gel and vaginal ring for women in preventing HIV
Channel Africa interviewed Sharon Hillier, Jim Kublin and Mitchell Warren.
South Africa’s Mail & Guardian published a supplement on the R4P conference.
All conference posters are available here. AVAC posters from R4P are available to download below.
Avac Event
This inaugural translational medicine conference: What Will it Take to Achieve an AIDS-Free World?, which will bring the audiences and editors of The Lancet and Cell together to bridge the gap between clinicians and researchers focused on understanding, managing, preventing and curing HIV/AIDS.
The ambition is to host a meeting every year that will address the most pressing topics in translational medicine. The 2013 inaugural conference will offer:
The desire to reach out and connect across disciplines can be hampered by lack of a common language. At the conference the editors of Cell and The Lancet will curate sessions that are designed to capture the energy at the interface between basic researchers and physicians that we hope will start new conversations that will catalyze the development of new translational approaches and solutions.
Avac Event
Hosted jointly by NAM and AVAC, the last webinar for 2013 in our series addressed a range of topics in HIV prevention research, including the development of the EATG/NAM community consensus statement on treatment as prevention, a set of principles intended to guide policy on access to antiretroviral therapy for prevention purposes for people with HIV, to be launched in January.
To view the full Flash animation of the webinar, click here.
Avac Event
The final webinar of the Fall series discussed what is known from social and behavioral science and community experience about the definitions and perceptions of HIV risk among women that are relevant to their potential PrEP use.
Avac Event
The second in a series of webinars by the US Women and PrEP Working Group discussed the possibilities and challenges associated with serodiscordant couples using PrEP to help them achieve pregnancy safely.
Avac Event
AIDS Vaccine 2013 took place from October 7–10 in Barcelona, Spain. AIDS Vaccine is the largest global scientific conference focused exclusively on AIDS vaccine research. Hosted annually by the Global HIV Vaccine Enterprise and local partners, AIDS Vaccine brings together the best and brightest scientific minds to exchange the latest research findings, explore new ideas, educate future leaders and engage a diverse community to help further research to develop a safe and effective HIV vaccine.
For the full program, click here . And, much of the conference is available via webcast here.
Avac Event
The US Women and PrEP Working Group held a webinar to discuss the latest in research and rollout of PrEP for women in the US. To learn more about the US Women and PrEP Working Group (and hear about upcoming webinars), visit www.prepwatch.org.